LEALING BIOPHARMA
Live / Registered — Registered (as of 23 Aug 2022)
What this means for you
Registered since 23 Aug 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90860167
- Registration number
- 6825724
- Mark type
- Stylized text
- Filed
- 02 Aug 2021
- Published for opposition
- 07 Jun 2022
- Registered
- 23 Aug 2022
Goods and services
- Class 005 — Pharmaceuticals: Immunostimulants; Biological preparations for the treatment of cancer; Biological preparations for the treatment of infectious diseases; Disinfecting wipes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents
Owner
- Liling biopharmaceuticals (Suzhou) Co., Ltd, Jiangsu, CN
- Liling biopharmaceuticals (Suzhou) Co., Ltd, Jiangsu, CN
- Liling biopharmaceuticals (Suzhou) Co., Ltd, Jiangsu, CN
Prosecution history
- 11 Jan 2025 — WITHDRAWAL OF ATTORNEY GRANTED
- 11 Jan 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 23 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 07 Jun 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jun 2022 — PUBLISHED FOR OPPOSITION
- 18 May 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 May 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 May 2022 — EXAMINER'S AMENDMENT ENTERED
- 03 May 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 03 May 2022 — EXAMINERS AMENDMENT E-MAILED
- 03 May 2022 — EXAMINERS AMENDMENT -WRITTEN
- 29 Apr 2022 — ASSIGNED TO EXAMINER
- 28 Sept 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 Aug 2021 — NEW APPLICATION ENTERED